Join Dr. Jonathan Silverberg for an engaging evening featuring international expertise and real world clinical perspectives on the management of moderate-to-severe atopic dermatitis.

Interactive sessions pair self-assessment with expert insights on AD treatments, IL-13 pathways, and biologic differentiation, plus personalized feedback to support improved patient outcomes.

At the conclusion of this program, participants will be better able to:

• Explain the root causes of AD inflammation and how these are targeted by advanced therapies
• Describe key findings and share clinical pearls from recent clinical trials and real-world experience to differentiate advanced therapies in moderate-to-severe AD
• Develop strategies for timely initiation of advanced treatment for moderate-to-severe AD to optimize clinical outcomes, reduce disease burden and reduce risk of relapse
• Evaluate and refine their approach to individualized treatment of moderate-to-severe AD through evidence-based decision-making

Dinner will be provided for attendees at in-person events.